About Nectar Lifesciences
Nectar Lifesciences is a company based in Chandigarh (India) founded in 1995. Nectar Lifesciences has raised $46.85 million across 1 funding round from investors including NSR Partners. The company has 1,790 employees as of March 31, 2024. Nectar Lifesciences offers products and services including Cephalosporin APIs, Formulations, and Empty Hard Gelatin Capsules.
- Headquarter Chandigarh, India
- Employees 1790 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nectar Lifesciences Ltd.
-
Annual Revenue
$195.82 M (USD)-0.74as on Mar 31, 2025
-
Net Profit
-$13.34 M (USD)-2375.9as on Mar 31, 2025
-
EBITDA
-$2.9 M (USD)-116.03as on Mar 31, 2025
-
Total Equity Funding
$46.85 M (USD)
in 1 rounds
-
Latest Funding Round
$46.85 M (USD), Private Equity Round
Mar 10, 2010
- Investors
-
Employee Count
1790
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nectar Lifesciences
Nectar Lifesciences is a publicly listed company on the NSE with ticker symbol NECLIFE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nectar Lifesciences
Nectar Lifesciences offers a comprehensive portfolio of products and services, including Cephalosporin APIs, Formulations, and Empty Hard Gelatin Capsules.
Manufactures antibiotics like Cefixime for global healthcare needs.
Produces tablets, capsules, and injectables for pharmaceutical use.
Provides capsules for formulation in pharmaceutical applications.
People of Nectar Lifesciences
Unlock access to complete
Funding Insights of Nectar Lifesciences
Nectar Lifesciences has successfully raised a total of $46.85M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $46.85 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nectar Lifesciences
Nectar Lifesciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NSR Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage private equity investments are pursued across sectors.
|
Locked | Locked | Locked |
Investor details for Nectar Lifesciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nectar Lifesciences
Investment portfolio details for Nectar Lifesciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nectar Lifesciences
Detailed financials for Nectar Lifesciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nectar Lifesciences Comparisons
Peer comparison for Nectar Lifesciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nectar Lifesciences
Detailed competitors of Nectar Lifesciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nectar Lifesciences
Complete news archive for Nectar Lifesciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nectar Lifesciences
Nectar Lifesciences was founded in 1995 and raised its 1st funding round 15 years after it was founded.
Nectar Lifesciences is headquartered in Chandigarh, India.
Amit Chadah is the current CEO of Nectar Lifesciences.
Nectar Lifesciences is a funded company, having raised a total of $46.85M across 1 funding round to date.
As of Mar 31, 2024, the latest employee count at Nectar Lifesciences is 1,790.
Annual revenue of Nectar Lifesciences is $195.82M as on Mar 31, 2025.
Nectar Lifesciences was founded in 1995 and is headquartered in Chandigarh, India. Operations in the pharmaceutical sector involve the production of cephalosporin active pharmaceutical ingredients and generic formulations. Additional offerings include contract research and manufacturing services, hard gelatin capsules, in vitro diagnostics, and natural extracts such as menthol and mint derivatives along with guar gum. Focus remains on core pharmaceutical manufacturing and related services.
Nectar Lifesciences offers Cephalosporin APIs, Formulations, and Empty Hard Gelatin Capsules.
Yes, Nectar Lifesciences is publicly traded on NSE under the ticker symbol NECLIFE.
Nectar Lifesciences has 1 investor. Key investors include NSR Partners.
The ticker symbol of Nectar Lifesciences is NECLIFE on NSE.